ALDEA Pharmaceuticals is developing a number of small-molecule modulators of the aldehyde dehydrogenase enzyme (ALDH) superfamily to address significant unmet medical needs.
home page
Latest News
"Aldehyde dehydrogenase-2 regulates nociception in rodent models of acute inflammatory pain" published in Science Translational Medicine
Aldea Pharmaceuticals Closes $24 Million Series B Financing. more...
"Targeting aldehyde dehydrogenase 2: New Therapeutic Opportunities" published in Physiological Reviews